TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Europe Acetaminophen Market Outlook and Forecast 2024-2030

Europe Acetaminophen Market Outlook and Forecast 2024-2030

  • Category:Chemicals and Materials
  • Published on : 06 December 2024
  • Pages :205
  • Formats:
  • Report Code:SMR-8022722

Europe Acetaminophen market size was valued at US$ 785.4 million in 2024 and is projected to reach US$ 985.6 million by 2030, at a CAGR of 3.8% during the forecast period 2024-2030.
Common analgesic and antipyretic drug.
Pharmaceutical manufacturing (60%,

TABLE OF CONTENTS

1 Market Overview    



1.1 Product Overview and Scope of Acetaminophen 



1.2 Segment by Type    



1.2.1 Europe Market Size YoY Growth Rate Analysis by Type: 2023 VS 2030    

1.2.2 Powder Grade    

1.2.3 Direct Compression Grade


1.3 Segment by Application  



1.3.1 Europe Market Size YoY Growth Rate Analysis by Application: 2023 VS 2030    

1.3.2    Tablet Drug

1.3.3    Granule Drug

1.3.4    Oral Drug

1.3.5    Other

1.4 Europe Market Growth Prospects    

1.4.1 Europe Revenue Estimates and Forecasts (2019-2030)    

1.4.2 Europe Production Estimates and Forecasts (2019-2030)  



2 Europe Growth Trends    



2.1 Industry Trends    

2.1.1 SWOT Analysis    

2.1.2 PESTEL Analysis    

2.1.3 Porter’s Five Forces Analysis    

2.2 Potential Market and Growth Potential Analysis    



3 Market Competition by Manufacturers  



3.1 Europe Production by Manufacturers (2019-2023)    

3.2 Europe Revenue Market Share by Manufacturers (2019-2023)    

3.3 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)    

3.4 Europe Average Price by Manufacturers (2019-2023)    

3.5 Manufacturers Production Sites, Area Served, Product Type    

3.6 Market Competitive Situation and Trends    

3.6.1 Market Concentration Rate    

3.6.2 Europe 5 and 10 Largest Players Market Share by Revenue    

3.6.3 Mergers & Acquisitions, Expansion  



4 Production by Region



4.1 Europe Production    

4.1.1 Europe Production YoY Growth Rate (2019-2023)    

4.1.2 Europe Production, Revenue, Price and Gross Margin (2019-2024)  



5 Consumption by Region  



5.1 Europe    

5.1.1 Europe Consumption by Country    

5.1.2 Europe Sales, Consumption, Export, Import (2019-2023)    

5.1.1 Germany    

5.2.2 United Kingdom

5.3.3 France

5.4.4 Italy

5.5.5 Spain

5.6.6 Netherlands

5.7.7 Belgium


6 Segment by Type   



6.1 Europe Production Market Share by Type (2019-2024)    

6.2 Europe Revenue Market Share by Type (2019-2024)    

6.3 Europe Price by Type (2019-2024) 



7 Segment by Application  



7.1 Europe Production Market Share by Application (2019-2024)    

7.2 Europe Revenue Market Share by Application (2019-2024)    

7.3 Europe Price by Application (2019-2024)  



8 Key Companies Profiled    



8.1 GlaxoSmithKline    

8.1.1 GlaxoSmithKline Corporation Information    

8.1.2 GlaxoSmithKline Product Portfolio    

8.1.3 GlaxoSmithKline Production Capacity, Revenue, Price and Gross Margin (2019-2024)    

8.1.4 GlaxoSmithKline Main Business and Markets Served    

8.1.5 GlaxoSmithKline Recent Developments/Updates    

8.2 Novartis AG    

8.2.1 Novartis AG Corporation Information    

8.2.2 Novartis AG Product Portfolio    

8.2.3 Novartis AG Production Capacity, Revenue, Price and Gross Margin (2019-2024)    

8.2.4 Novartis AG Main Business and Markets Served    

8.2.5 Novartis AG Recent Developments/Updates    

8.3 Bayer AG    

8.3.1 Bayer AG Corporation Information    

8.3.2 Bayer AG Product Portfolio    

8.3.3 Bayer AG Production Capacity, Revenue, Price and Gross Margin (2019-2024)    

8.3.4 Bayer AG Main Business and Markets Served    

8.3.5 Bayer AG Recent Developments/Updates    

8.4 Sanofi    

8.4.1 Sanofi Corporation Information    

8.4.2 Sanofi Product Portfolio    

8.4.3 Sanofi Production Capacity, Revenue, Price and Gross Margin (2019-2024)    

8.4.4 Sanofi Main Business and Markets Served    

8.4.5 Sanofi Recent Developments/Updates    

8.5 Reckitt Benckiser Group    

8.5.1 Reckitt Benckiser Group Corporation Information    

8.5.2 Reckitt Benckiser Group Product Portfolio    

8.5.3 Reckitt Benckiser Group Production Capacity, Revenue, Price and Gross Margin (2019-2024)    

8.5.4 Reckitt Benckiser Group Main Business and Markets Served    

8.5.5 Reckitt Benckiser Group Recent Developments/Updates    

8.6 Johnson & Johnson    

8.6.1 Johnson & Johnson Corporation Information    

8.6.2 Johnson & Johnson Product Portfolio    

8.6.3 Johnson & Johnson Production Capacity, Revenue, Price and Gross Margin (2019-2024)    

8.6.4 Johnson & Johnson Main Business and Markets Served    

8.6.5 Johnson & Johnson Recent Developments/Updates    

8.7 Stada Arzneimittel AG    

8.7.1 Stada Arzneimittel AG Corporation Information    

8.7.2 Stada Arzneimittel AG Production Capacity, Revenue, Price and Gross Margin (2019-2024)    

8.7.3 Stada Arzneimittel AG Main Business and Markets Served    

8.7.4 Stada Arzneimittel AG Recent Developments/Updates    

8.8 Teva Pharmaceutical Industries Ltd.    

8.8.1 Teva Pharmaceutical Industries Ltd. Corporation Information    

8.8.2 Teva Pharmaceutical Industries Ltd. Product Portfolio    

8.8.3 Teva Pharmaceutical Industries Ltd. Production Capacity, Revenue, Price and Gross Margin (2019-2024)    

8.8.4 Teva Pharmaceutical Industries Ltd. Main Business and Markets Served    

8.8.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates    

8.9 Boehringer Ingelheim    

8.9.1 Boehringer Ingelheim Corporation Information    

8.9.2 Boehringer Ingelheim Product Portfolio    

8.9.3 Boehringer Ingelheim Production Capacity, Revenue, Price and Gross Margin (2019-2024)    

8.9.4 Boehringer Ingelheim Main Business and Markets Served    

8.9.5 Boehringer Ingelheim Recent Developments/Updates    

8.10 AstraZeneca    

8.10.1 AstraZeneca Corporation Information    

8.10.2 AstraZeneca Product Portfolio    

8.10.3 AstraZeneca Production Capacity, Revenue, Price and Gross Margin (2019-2024)    

8.10.4 AstraZeneca Main Business and Markets Served    

8.10.5 AstraZeneca Recent Developments/Updates    


9 Manufacturing Cost Analysis    



9.1 Key Raw Materials Analysis    

9.1.1 Key Raw Materials    

9.1.2 Key Suppliers of Raw Materials    

9.2 Proportion of Manufacturing Cost Structure    

9.3 Manufacturing Process Analysis of Acetaminophen    

9.4 Industrial Chain Analysis    



10 Marketing Channel, Distributors and Customers  



 10.1 Marketing Channel    

10.2 Distributors List    

10.3 Customers    



11 Market Dynamics



11.1 Industry Trends    

11.2 Market Drivers    

11.3 Market Challenges    

11.4 Market Restraints    



12 Production and Supply Forecast



12.1 Europe Production, Revenue Forecast (2024-2030)    



13 Consumption and Demand Forecast  



 13.1 Europe Forecasted Consumption of by Country    



14 Forecast by Type and by Application  



14.1 Europe Production, Revenue and Price Forecast by Type (2024-2030)    

14.1.1 Europe Forecasted Production of by Type (2024-2030)    

14.1.2 Europe Forecasted Revenue of by Type (2024-2030)    

14.1.3 Europe Forecasted Price of by Type (2024-2030)    

14.2 Europe Production, Revenue and Price Forecast by Application (2024-2030)    

14.2.1 Europe Forecasted Production of by Application (2024-2030)    

14.2.2 Europe Forecasted Revenue of by Application (2024-2030)    

14.2.3 Europe Forecasted Price of by Application (2024-2030)  



15 Research Findings and Conclusion   



16 Methodology and Data Source    



16.1 Methodology/Research Approach    

16.1.1 Research Programs/Design    

16.1.2 Market Size Estimation    

16.1.3 Market Breakdown and Data Triangulation    

16.2 Data Source    

16.2.1 Secondary Sources    

16.2.2 Primary Sources    

16.3 Author List    

16.4 Disclaimer    



17 Appendix    



17.1 Note    

17.2 Examples of Clients    

LIST OF TABLES & FIGURES



Offer REPORT BUYING OPTIONS

USD GBP EURO YEN Single User Price
USD GBP EURO YEN Multi User Price
USD GBP EURO YEN Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount